SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-024121
Filing Date
2021-05-05
Accepted
2021-05-05 16:30:56
Documents
72
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vtvt-10q_20210331.htm 10-Q 1214043
2 EX-31.1 vtvt-ex311_8.htm EX-31.1 17627
3 EX-31.2 vtvt-ex312_6.htm EX-31.2 17519
4 EX-32.1 vtvt-ex321_7.htm EX-32.1 7257
5 EX-32.2 vtvt-ex322_9.htm EX-32.2 7212
6 GRAPHIC gruffkmytkcq000001.jpg GRAPHIC 141815
  Complete submission text file 0001564590-21-024121.txt   5333295

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT vtvt-20210331.xml EX-101.INS 923375
8 XBRL TAXONOMY EXTENSION SCHEMA vtvt-20210331.xsd EX-101.SCH 58596
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vtvt-20210331_cal.xml EX-101.CAL 39590
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vtvt-20210331_def.xml EX-101.DEF 230959
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtvt-20210331_lab.xml EX-101.LAB 407483
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtvt-20210331_pre.xml EX-101.PRE 316765
Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37524 | Film No.: 21893870
SIC: 2834 Pharmaceutical Preparations